Effect of Delivery Route on the Pharmacokinetics of Sufentanil NanoTab(R) in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2015
At a glance
- Drugs Sufentanil (Primary) ; Sufentanil (Primary) ; Sufentanil (Primary) ; Sufentanil (Primary)
- Indications Acute pain; Cancer pain; Postoperative pain
- Focus Pharmacokinetics
- Sponsors AcelRx Pharmaceuticals
- 02 May 2013 Results presented at American Society of Regional Anesthesia and Pain Medicine (ASRA) meeting, according to AcelRx Pharmaceuticals media release.
- 09 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2012 New trial record